Author Index

Search or browse for an author across our entire electronic archive

Search results for: O
Results 221 - 230 of 696 shown below

  • Oh, W K

    P Mathew, P F Thall, S Wen, C Bucana, D Jones, E Horne, W K Oh, M J Morris, Y-C Lee, C J Logothetis, S-H Lin and I J Fidler

    Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer

    advance online publication, 2008-10-07 00:00:00.000;

    doi:10.1038/sj.bjc.6604706

    Abstract | Full article | PDF

  • Oh, Y

    P Vorwerk, H Wex, B Hohmann, Y Oh, R G Rosenfeld and U Mittler

    CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL)

    doi:10.1054/bjoc.2000.1364

    Abstract | Full article | PDF

  • Oh-ishi, M

    K Araki, T Mikami, T Yoshida, M Kikuchi, Y Sato, M Oh-ishi, Y Kodera, T Maeda and I Okayasu

    High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach

    advance online publication, 2009-07-14 00:00:00.000;

    doi:10.1038/sj.bjc.6605163

    Abstract | Full article | PDF

  • Ohana, G

    G Ohana, S Bar-Yehuda, A Arich, L Madi, Z Dreznick, L Rath-Wolfson, D Silberman, G Slosman and P Fishman

    Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101

    doi:10.1038/sj.bjc.6601315

    Abstract | Full article | PDF

  • Ohashi, M

    M Ohashi, K Yoshida, M Kushida, Y Miura, S Ohnami, Y Ikarashi, Y Kitade, T Yoshida and K Aoki

    Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer

    advance online publication, 2005-08-02 00:00:00.000;

    doi:10.1038/sj.bjc.6602713

    Abstract | Full article | PDF

  • Ohashi, Y

    S Negoro, N Masuda, Y Takada, T Sugiura, S Kudoh, N Katakami, Y Ariyoshi, Y Ohashi, H Niitani and M Fukuoka

    Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

    doi:10.1038/sj.bjc.6600725

    Abstract | Full article | PDF

  • J Sakamoto, C Hamada, S Yoshida, S Kodaira, M Yasutomi, T Kato, K Oba, H Nakazato, S Saji and Y Ohashi

    An individual patient data meta-analysis of adjuvant therapy with uracil–tegafur (UFT) in patients with curatively resected rectal cancer

    advance online publication, 2007-03-20 00:00:00.000;

    doi:10.1038/sj.bjc.6603686

    Abstract | Full article | PDF

  • K Nouso, Y M Ito, K Kuwaki, Y Kobayashi, S Nakamura, Y Ohashi and K Yamamoto

    Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis

    advance online publication, 2008-03-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604282

    Abstract | Full article | PDF

  • S Okada, Y Sakata, S Matsuno, M Kurihara, Y Sasaki, Y Ohashi and T Taguchi

    Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study

    doi:10.1038/sj.bjc.6690375

    Abstract | Full article | PDF

  • Ohayon, T

    T Ohayon, R Gershoni-Baruch, M Z Papa, T Distelman Menachem, S Eisenberg Barzilai and E Friedman

    The R72P P53 mutation is associated with familial breast cancer in Jewish women

    advance online publication, 2005-03-01 00:00:00.000;

    doi:10.1038/sj.bjc.6602451

    Abstract | Full article | PDF

  • Ohbuchi, T

    K Hiraoka, M Miyamoto, Y Cho, M Suzuoki, T Oshikiri, Y Nakakubo, T Itoh, T Ohbuchi, S Kondo and H Katoh

    Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma

    advance online publication, 2006-01-17 00:00:00.000;

    doi:10.1038/sj.bjc.6602934

    Abstract | Full article | PDF

  • Ohdama, S

    M Sawada, S Miyake, S Ohdama, O Matsubara, S Masuda, K Yakumaru and Y Yoshizawa

    Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis

    doi:10.1038/sj.bjc.6690073

    Abstract | Full article | PDF

  • Ohe, Y

    I Sekine, Y Nishiwaki, R Kakinuma, K Kubota, F Hojo, T Matsumoto, H Ohmatsu, K Goto, T Kodama, K Eguchi, T Shinkai, T Tamura, Y Ohe, H Kunitoh, K Yoshimura and N Saijo

    Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507

    doi:10.1038/sj.bjc.6600800

    Abstract | Full article | PDF

  • C Tanai, H Nokihara, S Yamamoto, H Kunitoh, N Yamamoto, I Sekine, Y Ohe and T Tamura

    Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials

    advance online publication, 2009-03-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604982

    Abstract | Full article | PDF